Skip to main content
. 2014 Feb 18;9(2):e88814. doi: 10.1371/journal.pone.0088814

Figure 5. Increased survival of fCB-CD34+ cell-treated mice.

Figure 5

After lethal dose of LPS challenge (11 mg/kg, i.p.), mice were monitored for 7 days to determine the survival rate (n = 7 per group). *, P<0.01 versus PBS or CD34.